Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Myeloid 1

Conditions

Multiple Myeloma 5Waldenstrom Macroglobulinemia 1Recurrence 1Precancerous Conditions 1Neoplasms, Plasma Cell 1Medulloblastoma 1Mastocytosis, Systemic 1Lymphoma, Mantle-Cell 1Liver Neoplasms 1Leukemia, Large Granular Lymphocytic 1Ependymoma 1Carcinoma, Hepatocellular 1

Interventions

fludarabine phosphate 3Whole-Body Irradiation 3Tacrolimus 3Peripheral Blood Stem Cell Transplantation 3Mycophenolic Acid 3Melphalan 3Cyclophosphamide 3Busulfan 3Biopsy 3fludarabine 2Patient Reported Outcome Measures 2Mesna 2Colposcopy 2Aminolevulinic Acid 2tirbanibulin 1ruxolitinib 1Watchful Waiting 1Transurethral Resection of Prostate 1Thalidomide 1Tamoxifen 1Sirolimus 1Robotic Surgical Procedures 1Radiotherapy, Intensity-Modulated 1Pregnancy Tests 1Nivolumab 1Methotrexate 1Immunohistochemistry 1Hysterectomy 1Human Papillomavirus DNA Tests 1Etoposide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precancerous Conditions × Thalidomide × 1 year × Clear all
NCT00769587 2025-09-22

Thalidomide in Treating Patients With Relapsed or Progressive Systemic Mastocytosis

Centre Hospitalier Universitaire, Amiens

Completed
MyeloidOther neoplasm

Precancerous Conditions, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡